- £2.72bn
- £1.92bn
- £1.47bn
- 46
- 90
- 88
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,451 | 1,751 | 1,685 | 1,538 | 1,474 |
Cost of Revenue | |||||
Gross Profit | 2,362 | 1,674 | 1,543 | 1,456 | 1,398 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,225 | 1,078 | 570 | 2,153 | 1,480 |
Operating Profit | 226 | 673 | 1,115 | -615 | -6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 243 | 838 | 1,115 | -615 | -6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 215 | 853 | 995 | -549 | 12 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 266 | 833 | 994 | -550 | 12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 266 | 833 | 994 | -550 | 12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.151 | 0.202 | -0.094 | 0.059 | 0.111 |
Dividends per Share |